Q&A with Xiyin Wang: Targeting a Shared Vulnerability in Breast and Ovarian Cancer

Xiyin Wang, a graduate student at Mayo Clinic, received a 2024 PhRMA Foundation Predoctoral Fellowship in Drug Discovery for his research on a common molecular feature essential for the survival of both breast and ovarian cancer. He is now investigating a potential drug candidate that targets this shared cellular vulnerability. Watch this video to learn about Wang and his research.